Thursday, March 18, 2010

New Biotechnology reports published this week

Chiral Technology: Global Markets (BIO012E)

BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for chiral products and technologies used in today’s world. The key objective is to present a comprehensive analysis of the current market and its future direction in the chiral market as an important tool for diagnosis of various diseases.

This report explores present and future strategies within the chiral market, including the synthesis, separation, and analysis of the chiral products. The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. An overview of chirality, the chiral products, and the technologies used in past and present are depicted in the report.

A detailed analysis of the chiral industry structure has been conducted. This includes the chiral synthesis, chiral separation/resolution, and the chiral analysis. Revenues are broken down by the region. Sales figures are estimated for the 5-year period from 2009 through 2014.

Applications for chiral products and technologies are also discussed separately in the report, with emphasis of the usage in pharmaceutical, biochemical, and agrochemical industries. The report also covers significant patents and their allotments in each category.

Therapeutic Vaccines: The Global Market (BIO052B)

BCC’s goal in conducting this study was to determine the current status of the therapeutic vaccines industry and assess its growth potential over a 5-year period from 2010 to 2015. Only a handful of such therapeutics has entered clinical use as of the beginning of 2010. For each therapeutic vaccine on the market and almost all therapeutic vaccines in mid-to-late stages of development, we have examined where they stand in the drug development process, major challenges to their approval or market success, achievements and, where applicable, the projected market for each of these drugs through 2014.

We were particularly interested in up-and-coming therapeutic vaccines in phase II or III clinical trials. We identify the leading candidates for therapeutic vaccines by disease application and also vaccine technology. In some cases we discuss notable vaccines that failed in clinical testing.

Our key objective is to present a comprehensive analysis of the current therapeutic vaccines market and its future direction.

For more information and to download the introduction chapter for free, please visit

No comments:

Post a Comment

Bookmark and Share